Marta Silva de Lapuerta has been proposed as an independent director of Mapfre, with the appointment awaiting approval at the insurer’s next ordinary general shareholders’ meeting. Forbes España reported that Silva would replace Antonio Gómez Ciria when his mandate expires.
The change is a governance renewal rather than an executive appointment. Mapfre’s board approved the proposal after the company’s Nominations and Remuneration Committee recommended it. Gómez Ciria’s mandate ends at the next meeting, and Mapfre’s statutes set March 25, 2027 as the maximum age for directors, giving the transition a clear timetable.
A board seat with institutional experience
El Español also confirmed the proposal, including the requirement for shareholder ratification. Silva has served as secretary general of Cesce since 2018. Earlier in her career she was a State Attorney and held legal roles connected to Spain’s public administration; those facts are context, not the frame of this corporate appointment.
The immediate point for Mapfre is the composition of its board. Silva brings experience in legal oversight and corporate governance, while the company’s process leaves shareholders with the formal decision at the ordinary meeting. That is a useful distinction: the board has proposed the change, but the seat is not final until the vote.
The move fits the broader governance question behind director appointments: how a board refreshes its experience without turning a routine handover into a spectacle. Readers saw a different version of that question when Zurich named Alex Wells to lead its U.S. business; Mapfre’s change is quieter, but the governing table is where the next chapter starts.\n\nThe next ordinary meeting is the concrete milestone to watch. Until shareholders vote, the proposal remains a board recommendation rather than a completed appointment. That procedural step is part of the substance: independent directors enter through a process designed to make the change visible to owners, and the timetable gives Mapfre a defined moment to close one mandate and begin another. No broader management change was announced alongside Silva’s nomination. In other words, the appointment is significant precisely because it is orderly: a board refresh with a visible approval step, a named predecessor and a documented reason for the change.
